Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E4LC
|
||||
Former ID |
DIB019944
|
||||
Drug Name |
GSK1511931
|
||||
Synonyms |
GSK1511931A; GSK-1511931; compound 14 [PMID: 19081716]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529864] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H32N8O
|
||||
InChI |
InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)
|
||||
InChIKey |
PEPOAPKYASCEKL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Insulin-like growth factor 1 receptor | Target Info | Inhibitor | [529864] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
HIF-1 signaling pathway | |||||
FoxO signaling pathway | |||||
Oocyte meiosis | |||||
Endocytosis | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Focal adhesion | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Long-term depression | |||||
Ovarian steroidogenesis | |||||
Progesterone-mediated oocyte maturation | |||||
Pathways in cancer | |||||
Transcriptional misregulation in cancer | |||||
Proteoglycans in cancer | |||||
Glioma | |||||
Prostate cancer | |||||
Melanoma | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.